[Miliary tuberculosis as a complication of BCG immunotherapy in cancer of the bladder. Case report].
Intravesical administration of BCG may be used as an ancillary immunotherapy after endoscopic resection for cancer of the bladder. Local side effects are usually mild. Here is reported a patient who developed miliary tuberculosis after this form of therapy. Radiologic studies of the thorax and liver biopsy confirmed the diagnosis. The patient recovered after treatment with anti-tuberculosis drugs (TA-81 scheme). Epithelial trauma may be invoked as an alteration facilitating this complication. Although it develops infrequently, patients with bladder cancer treated with BCG must be monitored for this complication.
Arrese
M
M
Departamento de Gastroenterología, Escuela de Medicina, Pontificia Universidad Católica, Santiago de Chile.
Ebel
L
L
Hofmann
E
E
Gaete
P
P
Jara
A
A
Cabrera
K
K
Araos
F
F
Del Río
P
P
Valdivieso
V
V
D001500:BCG Vaccine / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D008297:Male; D008875:Middle Aged; D014391:Tuberculosis, Miliary / Q000175:diagnosis / Q000209:etiology*; D001749:Urinary Bladder Neoplasms / Q000628:therapy*
D001500:BCG Vaccine
Tuberculosis miliar como complicacion de inmunoterapia con BCG en el cancer de vejiga. Caso clinico.